However, there may be an association between DPP-4 inhibitors and the onset of autoimmune diseases, such as bullous pemphigoid and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome [23–26]. The gene discussed is DPP4; the disease is autoimmune disease.